Profile data is unavailable for this security.
About the company
Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
- Revenue in HKD (TTM)654.37bn
- Net income in HKD7.74bn
- Incorporated2003
- Employees100.25k
- LocationSinopharm Group Co LtdSinopharm Group Building, No. 385, EastSHANGHAI 200023ChinaCHN
- Phone+86 2 123052666
- Fax+86 2 123052888
- Websitehttps://www.sinopharmgroup.com.cn/
| Holder | Shares | % Held |
|---|---|---|
| Lazard Asset Management LLCas of 02 Feb 2026 | 148.39m | 11.06% |
| Fidelity Management & Research Co. LLCas of 23 Sep 2025 | 70.75m | 5.27% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 57.37m | 4.28% |
| BlackRock Fund Advisorsas of 17 Feb 2026 | 54.73m | 4.08% |
| FIAM LLCas of 23 Sep 2025 | 40.87m | 3.05% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 28.58m | 2.13% |
| BlackRock Advisors (UK) Ltd.as of 17 Feb 2026 | 22.73m | 1.69% |
| Wasatch Advisors LPas of 30 Sep 2025 | 21.39m | 1.59% |
| Fidelity Investments Canada ULCas of 31 Dec 2025 | 16.05m | 1.20% |
| Geode Capital Management LLCas of 25 Feb 2026 | 16.00m | 1.19% |
